182 related articles for article (PubMed ID: 28978007)
21. Type 2 Diabetes, Antidiabetic Medications, and Colorectal Cancer Risk: Two Case-Control Studies from Italy and Spain.
Rosato V; Tavani A; Gracia-Lavedan E; Guinó E; Castaño-Vinyals G; Villanueva CM; Kogevinas M; Polesel J; Serraino D; Pisa FE; Barbone F; Moreno V; La Vecchia C; Bosetti C
Front Oncol; 2016; 6():210. PubMed ID: 27766252
[TBL] [Abstract][Full Text] [Related]
22. Sex disparities in treatment patterns after metformin initiation among patients with type 2 diabetes mellitus.
Oktora MP; de Vos S; de Vries ST; Hak E; Denig P
Pharmacoepidemiol Drug Saf; 2023 Dec; 32(12):1395-1405. PubMed ID: 37524658
[TBL] [Abstract][Full Text] [Related]
23. Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
Haring A; Murtola TJ; Talala K; Taari K; Tammela TL; Auvinen A
Scand J Urol; 2017 Feb; 51(1):5-12. PubMed ID: 28084175
[TBL] [Abstract][Full Text] [Related]
24. Metformin added to intensive insulin therapy improves metabolic control in patients with type 1 diabetes and excess body fat.
Zawada A; Naskręt D; Burchardt P; Niedźwiecki P; Piłaciński S; Wierusz-Wysocka B; Grzymisławski M; Zozulińska-Ziółkiewicz D
Pol Arch Intern Med; 2018 May; 128(5):294-300. PubMed ID: 29870029
[TBL] [Abstract][Full Text] [Related]
25. Gender-specific Effects of Treatment with Lifestyle, Metformin or Sulfonylurea on Glycemic Control and Body Weight: A German Multicenter Analysis on 9 108 Patients.
Schütt M; Zimmermann A; Hood R; Hummel M; Seufert J; Siegel E; Tytko A; Holl RW; ;
Exp Clin Endocrinol Diabetes; 2015 Nov; 123(10):622-6. PubMed ID: 26285070
[TBL] [Abstract][Full Text] [Related]
26. Factors Associated with Type 2 Diabetes Mellitus Treatment Choice Across Four European Countries.
Heintjes EM; Overbeek JA; Hall GC; Prieto-Alhambra D; Lapi F; Hammar N; Bezemer ID
Clin Ther; 2017 Nov; 39(11):2296-2310.e14. PubMed ID: 29108837
[TBL] [Abstract][Full Text] [Related]
27. [Molecular action of insulin-sensitizing agents].
Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
[TBL] [Abstract][Full Text] [Related]
28. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
[TBL] [Abstract][Full Text] [Related]
29. Metformin use and risk of cancer in patients with type 2 diabetes: a cohort study of primary care records using inverse probability weighting of marginal structural models.
Farmer RE; Ford D; Mathur R; Chaturvedi N; Kaplan R; Smeeth L; Bhaskaran K
Int J Epidemiol; 2019 Apr; 48(2):527-537. PubMed ID: 30753459
[TBL] [Abstract][Full Text] [Related]
30. Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis.
Bodmer M; Becker C; Meier C; Jick SS; Meier CR
Cancer Epidemiol Biomarkers Prev; 2012 Feb; 21(2):280-6. PubMed ID: 22178569
[TBL] [Abstract][Full Text] [Related]
31. Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.
Roberts VL; Stewart J; Issa M; Lake B; Melis R
Clin Ther; 2005 Oct; 27(10):1535-47. PubMed ID: 16330290
[TBL] [Abstract][Full Text] [Related]
32. Assessment of Diabetic Polyneuropathy in Inpatient Care: Fasting Blood Glucose, HbA1c, Electroneuromyography and Diabetes Risk Factors.
Suljic E; Kulasin I; Alibegovic V
Acta Inform Med; 2013; 21(2):123-6. PubMed ID: 24039336
[TBL] [Abstract][Full Text] [Related]
33. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.
Currie CJ; Poole CD; Gale EA
Diabetologia; 2009 Sep; 52(9):1766-77. PubMed ID: 19572116
[TBL] [Abstract][Full Text] [Related]
34. Metformin as a potential protective therapy against tuberculosis in patients with diabetes mellitus: A retrospective cohort study in a single teaching hospital.
Fu CP; Lee CL; Li YH; Lin SY
J Diabetes Investig; 2021 Sep; 12(9):1603-1609. PubMed ID: 33550691
[TBL] [Abstract][Full Text] [Related]
35. Impact of glycemic traits, type 2 diabetes and metformin use on breast and prostate cancer risk: a Mendelian randomization study.
Au Yeung SL; Schooling CM
BMJ Open Diabetes Res Care; 2019; 7(1):e000872. PubMed ID: 31908803
[TBL] [Abstract][Full Text] [Related]
36. Gender-specific care of the patient with diabetes: review and recommendations.
Legato MJ; Gelzer A; Goland R; Ebner SA; Rajan S; Villagra V; Kosowski M;
Gend Med; 2006 Jun; 3(2):131-58. PubMed ID: 16860272
[TBL] [Abstract][Full Text] [Related]
37. Increased urinary albumin excretion, insulin resistance, and related cardiovascular risk factors in patients with type 2 diabetes: evidence of a sex-specific association.
De Cosmo S; Minenna A; Ludovico O; Mastroianno S; Di Giorgio A; Pirro L; Trischitta V
Diabetes Care; 2005 Apr; 28(4):910-5. PubMed ID: 15793194
[TBL] [Abstract][Full Text] [Related]
38. The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature.
Tseng CH
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356646
[TBL] [Abstract][Full Text] [Related]
39. The risk of prostate cancer for men on aspirin, statin or antidiabetic medications.
Nordström T; Clements M; Karlsson R; Adolfsson J; Grönberg H
Eur J Cancer; 2015 Apr; 51(6):725-33. PubMed ID: 25727881
[TBL] [Abstract][Full Text] [Related]
40. Use of Add-on Treatment to Metformin Monotherapy for Patients with Type 2 Diabetes and Suboptimal Glycemic Control: A U.S. Database Study.
Yu S; Schwab P; Bian B; Radican L; Tunceli K
J Manag Care Spec Pharm; 2016 Mar; 22(3):272-80. PubMed ID: 27003557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
